During the past decade, Sykehuset Innlandet Gjøvik conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sykehuset Innlandet Gjøvik" #1 sponsor was "Norwegian University of Science and Technology" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Diakonhjemmet Hospital" with 1 trials sponsored and "Oslo University Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sykehuset Innlandet Gjøvik" #1 collaborator was "Sykehuset Innlandet HF" with 3 trials as a collaborator, "Alesund Hospital" with 2 trials as a collaborator, "St. Olavs Hospital" with 2 trials as a collaborator, "University Hospital of North Norway" with 2 trials as a collaborator and "Ferrosan AS" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Sykehuset Innlandet Gjøvik" are "Crohn's Disease" (2 trials), "Acute Cardiovascular Disease" (1 trials), "Acute Pain" (1 trials), "Acute Respiratory Disease" (1 trials) and "Ambulances" (1 trials). Many other conditions were trialed in "Sykehuset Innlandet Gjøvik" in a lesser frequency.

Most popular intervention types in "Sykehuset Innlandet Gjøvik" are "Drug" (6 trials), "Biological" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials), "Placebo" (2 trials) and "45 Gy in 30 fractions" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sykehuset Innlandet Gjøvik" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Sykehuset Innlandet Gjøvik". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sykehuset Innlandet Gjøvik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sykehuset Innlandet Gjøvik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".